Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-25

Clinical Trial Update: Atrial Fibrillation Ablation and Autonomic Modulation Via Thorascopic Surgery [Phase 4]

View source ↗

Summary

This clinical trial update notes that the Phase 4 study of atrial fibrillation ablation with autonomic modulation via thorascopic surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED